Dalfampridine 42571-0275
Product NDC
42571-0275- Manufacturer
- Micro Labs Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 21, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210158
Need to source Dalfampridine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dalfampridine | 10 mg/1 |
Drug Class
Potassium Channel Blocker [EPC]Potassium Channel Antagonists [MoA]Potassium Channel Blocker [EPC]
Packaging Options(3)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-05)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-10)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-60)